The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has led to sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga.
In a statement Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business." - NPR
Im good with this, I have naked put position here so this upside move gives me some good wiggle room.
Submitted May 19, 2014 at 09:51AM by StockJock-e http://ift.tt/1sL3QZn
No comments:
Post a Comment